Case number 2015-1962
Andrulis Pharmaceuticals Corp. v. Celgene Corporation > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | ANDRULIS PHARMACEUTICALS CORP. v. CELGENE CORPORATION [RULE 36 JUDGMENT] [nonprecedential] (0) |
| Aug 22, 2016 | 48 | Mandate issued to the United States District Court for the District of Delaware. Service as of this date by Clerk of Court. [360689] [CAB] [Entered: 08/22/2016 11:16 AM] (1) |
| Jul 14, 2016 | 47 | OPINION and JUDGMENT filed. The judgment or decision is: Affirmed. (FCR 36). (For the Court: Prost,Chief Judge; Schall,Circuit Judge and Chen,Circuit Judge). [350669] [CAB] [Entered: 07/14/2016 09:10 AM] (5) |
| Jul 8, 2016 | 46 | Submitted after ORAL ARGUMENT by Eliot James Walker for Andrulis Pharmaceuticals Corporation and Calvin P. Griffith, Esq. for Celgene Corporation. Panel: Judge: Prost , Judge: Schall , Judge: Chen. [349385] [LAJ] [Entered: 07/08/2016 12:06 PM] (0) |
| Jun 15, 2016 | 45 | Response to oral argument order from the Appellant Andrulis Pharmaceuticals Corporation. designating Eliot J. Walker as arguing attorney. Designated time for argument: 12 minutes. Designated time for rebuttal: 3 minutes. Service of other counsel by Notice of Docket Activity from this entry. [343919] [Eliot Walker] [Entered: 06/15/2016 03:59 PM] (0) |
| Jun 14, 2016 | 44 | Response to oral argument order from the Appellee Celgene Corporation. designating Calvin P. Griffith as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [343334] [Jennifer Swize] [Entered: 06/14/2016 12:05 PM] (0) |
| May 20, 2016 | 43 | NOTICE OF CALENDARING. Panel: 1607I. Case scheduled Jul 08, 2016 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, N.W. Washington, DC 20439), Courtroom 402. Response to oral argument order due: 06/15/2016. Counsel should check-in 30 minutes prior to the opening of the session. Please review the Oral Argument Order. [337156] THIS NOTICE APPLIES TO CASE(S): [15-1329, 15-1962, 15-3148, 16-1098] [JAB] [Entered: 05/20/2016 01:04 PM] (0) |
| Mar 16, 2016 | 42 | 6 paper copies of the appendix Brief [41] received from Appellant Andrulis Pharmaceuticals Corporation. [319216] [LAJ] [Entered: 03/16/2016 03:37 PM] (0) |
| Mar 14, 2016 | 41 | APPENDIX FILED for Andrulis Pharmaceuticals Corporation [40]. Number of Pages: 304. Service: 03/14/2016 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 03/21/2016. [318569] [JCA] [Entered: 03/15/2016 09:03 AM] (304) |
| Mar 14, 2016 | 40 | TENDERED from Appellant Andrulis Pharmaceuticals Corporation. Title: JOINT APPENDIX. Service: 03/14/2016 by email. [318492] [Paul Skiermont] [Entered: 03/14/2016 05:28 PM] (304) |
| Mar 10, 2016 | 39 | Statement of Compliance with Fed. Cir. R. 33 for Appellant Andrulis Pharmaceuticals Corporation and Appellee Celgene Corporation. Service: 03/10/2016 by email. [317664] [Paul Skiermont] [Entered: 03/10/2016 07:43 PM] (4) |
| Mar 8, 2016 | 38 | 6 paper copies of the Reply Brief [37] received from Appellant Andrulis Pharmaceuticals Corporation. [316836] [LAJ] [Entered: 03/08/2016 04:06 PM] (0) |
| Mar 4, 2016 | 37 | REPLY BRIEF FILED for Appellant Andrulis Pharmaceuticals Corporation [36]. Number of Pages: 19. Service: 03/04/2016 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 03/14/2016. Appendix is due 03/14/2016. [316249] [CAB] [Entered: 03/07/2016 11:30 AM] (29) |
| Mar 4, 2016 | 36 | TENDERED from Appellant Andrulis Pharmaceuticals Corporation. Title: REPLY BRIEF. Service: 03/04/2016 by email. [316058] [Paul Skiermont] [Entered: 03/04/2016 03:43 PM] (29) |
| Feb 18, 2016 | 35 | 6 paper copies of the Opening Response Brief [34] received from Appellee Celgene Corporation. [312105] [LAJ] [Entered: 02/18/2016 02:05 PM] (0) |
| Feb 16, 2016 | 34 | BRIEF FILED for Appellee Celgene Corporation [33]. Number of Pages: 55. Service: 02/16/2016 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 02/22/2016. Appellant Andrulis Pharmaceuticals Corporation's reply brief is due 03/04/2016. [311721] [CAB] [Entered: 02/17/2016 12:27 PM] (66) |
| Feb 16, 2016 | 33 | TENDERED from Appellee Celgene Corporation. Title: RESPONSE BRIEF. Service: 02/16/2016 by email. [311523] [Daniel Kazhdan] [Entered: 02/16/2016 07:55 PM] (66) |
| Feb 12, 2016 | 32 | Entry of appearance for Eliot J. Walker as of counsel for Appellant Andrulis Pharmaceuticals Corporation. Service: 02/12/2016 by email. [310858] [Eliot Walker] [Entered: 02/12/2016 04:24 PM] (1) |
| Feb 4, 2016 | 31 | Amended Certificate of Interest for the Appellee Celgene Corporation. Service: 02/04/2016 by email. [308665] [Daniel Kazhdan] [Entered: 02/04/2016 04:19 PM] (2) |
| Feb 4, 2016 | 30 | Entry of appearance for Daniel Kazhdan as of counsel for Appellee Celgene Corporation. Service: 02/04/2016 by email. [308663] [Daniel Kazhdan] [Entered: 02/04/2016 04:16 PM] (2) |
| Jan 22, 2016 | 25 | Notice of Change of Firm Name. Service: 01/22/2016 by email. [305540] [Steven Udick] [Entered: 01/22/2016 01:07 PM] (5) |
| Jan 22, 2016 | 26 | Amended Certificate of Interest for the Appellant Andrulis Pharmaceuticals Corporation. Service: 01/22/2016 by email. [305541] [Steven Udick] [Entered: 01/22/2016 01:08 PM] (3) |
| Jan 22, 2016 | 27 | Amended Entry of appearance for Steven Udick as of counsel for Appellant Andrulis Pharmaceuticals Corporation. Service: 01/22/2016 by email. [305542] [Steven Udick] [Entered: 01/22/2016 01:09 PM] (1) |
| Jan 22, 2016 | 28 | Amended Entry of appearance for Paul J. Skiermont as principal counsel for Appellant Andrulis Pharmaceuticals Corporation. Service: 01/22/2016 by email. [305543] [Paul Skiermont] [Entered: 01/22/2016 01:12 PM] (1) |
| Jan 22, 2016 | 29 | Amended Entry of appearance for Sarah E. Spires as of counsel for Appellant Andrulis Pharmaceuticals Corporation. Service: 01/22/2016 by email. [305544] [Sarah Spires] [Entered: 01/22/2016 01:14 PM] (1) |
| Dec 28, 2015 | 23 | MOTION of Appellee Celgene Corporation to extend the time to 02/16/2016 to file the appellee/respondent/cross-appellant's principal brief. Response/Opposition is due 01/07/2016 [Consent: unopposed]. Service: 12/24/2015 by email. [298701] [Jennifer Swize] [Entered: 12/24/2015 11:11 AM] (8) |
| Dec 28, 2015 | 24 | **TEXT ONLY** ORDER granting motion to extend time to file appellee/respondent/cross-appellant principal brief [23] filed by Appellee Celgene Corporation Appellee Celgene Corporation brief due 02/16/2016. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [298785] [JCA] [Entered: 12/28/2015 10:22 AM] (0) |
| Dec 3, 2015 | 22 | 6 paper copies of the Opening Brief [21] received from Appellant Andrulis Pharmaceuticals Corporation. [293533] [MJL] [Entered: 12/04/2015 08:07 AM] (0) |
| Dec 2, 2015 | 21 | BRIEF FILED for Appellant Andrulis Pharmaceuticals Corporation [20]. Number of Pages: 42. Service: 12/02/2015 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 12/08/2015. Appellee Celgene Corporation brief is due 01/14/2016. [293258] [CAB] [Entered: 12/03/2015 10:36 AM] (83) |
| Dec 2, 2015 | 20 | TENDERED from Appellant Andrulis Pharmaceuticals Corporation. Title: OPENING BRIEF. Service: 12/02/2015 by email. [293116] [Paul Skiermont] [Entered: 12/02/2015 05:26 PM] (83) |
| Oct 27, 2015 | 19 | **TEXT ONLY** ORDER granting motion to extend time to file appellant/petitioner principal brief [18] filed by Appellant Andrulis Pharmaceuticals Corporation Brief due 12/02/2015. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [283771] [JW] [Entered: 10/27/2015 01:07 PM] (0) |
| Oct 26, 2015 | 18 | MOTION of Appellant Andrulis Pharmaceuticals Corporation to extend the time to 12/02/2015 at 11:59 pm to file the appellant/petitioner's principal brief. Response/Opposition is due 11/09/2015 [Consent: unopposed]. Service: 10/26/2015 by email. [283495] [Steven Udick] [Entered: 10/26/2015 04:09 PM] (8) |
| Oct 16, 2015 | 17 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellee Celgene Corporation. Service: 10/16/2015 by email. [281074] [Jennifer Swize] [Entered: 10/16/2015 02:56 PM] (3) |
| Oct 16, 2015 | 16 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellant Andrulis Pharmaceuticals Corporation. Service: 10/16/2015 by email. [281022] [Steven Udick] [Entered: 10/16/2015 01:24 PM] (4) |
| Sep 29, 2015 | 15 | Entry of appearance for John C. Evans as of counsel for Appellee Celgene Corporation. Service: 09/29/2015 by email. [275876] [Jennifer Swize] [Entered: 09/29/2015 10:09 AM] (2) |
| Sep 17, 2015 | 14 | Corrected Entry of appearance for Sarah E. Spires as of counsel for Appellant Andrulis Pharmaceuticals Corporation. Service: 09/17/2015 by email. [273230] [Steven Udick] [Entered: 09/17/2015 04:13 PM] (1) |
| Sep 17, 2015 | 13 | Corrected Entry of appearance for Steven Udick as of counsel for Appellant Andrulis Pharmaceuticals Corporation. Service: 09/17/2015 by email. [273096] [Steven Udick] [Entered: 09/17/2015 11:27 AM] (1) |
| Sep 17, 2015 | 12 | NOTICE OF DEFICIENCY: The attorney entry of appearance Document No. [9] and [8] filed by Appellant Andrulis Pharmaceuticals Corporation in 15-1962 are incomplete (Attorneys Sarah Spires and Steven Udick's designations were not completed). Therefore, these documents cannot be accepted for filing at this time. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [272956] [CAB] [Entered: 09/17/2015 09:48 AM] (0) |
| Sep 15, 2015 | 11 | Docketing Statement for the Appellant Andrulis Pharmaceuticals Corporation. Service: 09/15/2015 by email. [272405] [Paul Skiermont] [Entered: 09/15/2015 02:55 PM] (3) |
| Sep 15, 2015 | 10 | Certificate of Interest for the Appellant Andrulis Pharmaceuticals Corporation. Service: 09/15/2015 by email. [272403] [Paul Skiermont] [Entered: 09/15/2015 02:54 PM] (3) |
| Sep 15, 2015 | 9 | Entry of appearance for Steven Udick as of counsel for Appellant Andrulis Pharmaceuticals Corporation. Service: 09/15/2015 by email. [272402] [Paul Skiermont] [Entered: 09/15/2015 02:53 PM] (0) |
| Sep 15, 2015 | 8 | Entry of appearance for Sarah E. Spires as of counsel for Appellant Andrulis Pharmaceuticals Corporation. Service: 09/15/2015 by email. [272401] [Paul Skiermont] [Entered: 09/15/2015 02:52 PM] (0) |
| Sep 15, 2015 | 7 | Entry of appearance for Paul Skiermont as principal counsel for Appellant Andrulis Pharmaceuticals Corporation. Service: 09/15/2015 by email. [272399] [Paul Skiermont] [Entered: 09/15/2015 02:51 PM] (1) |
| Sep 15, 2015 | 6 | Docketing Statement for the Appellee Celgene Corporation. Service: 09/15/2015 by email. [272262] [Jennifer Swize] [Entered: 09/15/2015 11:53 AM] (3) |
| Sep 11, 2015 | 5 | Certificate of Interest for the Appellee Celgene Corporation. Service: 09/11/2015 by email. [271484] [Jennifer Swize] [Entered: 09/11/2015 01:40 PM] (2) |
| Sep 11, 2015 | 4 | Entry of appearance for Jennifer L. Swize as of counsel for Appellee Celgene Corporation. Service: 09/11/2015 by email. [271483] [Jennifer Swize] [Entered: 09/11/2015 01:39 PM] (2) |
| Sep 11, 2015 | 3 | Entry of appearance for Anthony M. Insogna as of counsel for Appellee Celgene Corporation. Service: 09/11/2015 by email. [271482] [Jennifer Swize] [Entered: 09/11/2015 01:39 PM] (2) |
| Sep 11, 2015 | 2 | Entry of appearance for Calvin P. Griffith as principal counsel for Appellee Celgene Corporation. Service: 09/11/2015 by email. [271480] [Jennifer Swize] [Entered: 09/11/2015 01:37 PM] (2) |
| Sep 1, 2015 | 1 | Appeal docketed. Received: 08/28/2015. [268492]Entry of Appearance due 09/15/2015. Certificate of Interest is due on 09/15/2015. Docketing Statement due 09/15/2015. Appellant/Petitioner's brief is due 11/02/2015. [CAB] [Entered: 09/01/2015 11:04 AM] (21) |
